RECOVAC Repeated Vaccination Study

NCT05030974 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

336

Enrollment

OTHER

Sponsor class

Conditions

Covid19
Kidney Diseases
Vaccine Response Impaired
SARS-CoV2 Infection

Interventions

BIOLOGICAL: mRNA-1273
BIOLOGICAL: Ad26.COV2.S vaccine

Sponsor

University Medical Center Groningen

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]